Modulight Oyj

Equities

MODU

FI4000511506

Advanced Medical Equipment & Technology

Delayed Nasdaq Helsinki Other stock markets 10:55:48 2024-04-30 am EDT			5-day change	1st Jan Change
0.886 ^EUR	+5.48%		-3.49%	-24.53%

Apr. 29	Transcript : Modulight Oyj, Q1 2024 Earnings Call, Apr 29, 2024
Apr. 27	Modulight Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Change in Modulight Corporation’s holding of treasury shares and annulment of option rights

September 29, 2023 at 08:31 am EDT

Modulight Corporation | Company Release | September 29, 2023 at 15:30:00 EEST

Modulight Corporation issued 815,859 new shares and 852,758 option rights to its employees in a personnel share issue in September 2021. The issuance of shares was carried out in deviation from shareholders’ pre-emptive right (directed issue) in order to engage and retain employees.

Modulight Corporation has acquired a total of 51,123 shares subscribed in the personnel share issue from an employee whose employment with Modulight Corporation has ended, in accordance with the terms and conditions of the directed share issue. The purchase price is EUR 0.32 per share, which is the original subscription price. In addition, Modulight Corporation annuls 62,364 option rights which have been returned to the possession of Modulight Corporation due to an ended employment.

The shares were acquired on 29 September 2023. After the acquisition, Modulight Corporation holds a total of 51,123 treasury shares. After the annulment of the option rights, Modulight Corporation does not hold any option rights.

MODULIGHT CORPORATION

For further information, please contact:

CEO: Seppo Orsila, m. +358 40 830 4671

IR: Ulla Haapanen, m. +358 40 830 4676
Email: ir@modulight.com

Certified Adviser:
Danske Bank A/S, Finland Branch, m. +358 40 414 5358

www.modulight.com
Twitter: @modulight, @orsila

Modulight in brief

Modulight Corporation is a biomedical laser company that designs and manufactures products for oncology, ophthalmology and genetics. The company also provides solutions for selected high value-add applications including quantum computing and digital press. The company’s products include medical devices, subsystems, software, cloud services and specialized semiconductors. Modulight’s products are used worldwide by many Fortune 500 companies, pharmaceutical companies, and well-known cancer centers and universities. Modulight was founded in 2000 and is headquartered in Tampere, Finland. www.modulight.com

Latest news about Modulight Oyj

Transcript : Modulight Oyj, Q1 2024 Earnings Call, Apr 29, 2024	Apr. 29
Modulight Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 26	CI
Modulight Oyj Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 23	CI
Transcript : Modulight Oyj, 2023 Earnings Call, Feb 23, 2024	Feb. 23
Finland's Modulight Marks UK, Irish Expansion with Laser 2000 UK Sales Partnership	Feb. 09	MT
Modulight Forges Strategic Partnership with Laser 2000 (Uk) Limited for Market Expansion in the Uk and Ireland	Feb. 09	CI
Transcript : Modulight Oyj, Q3 2023 Earnings Call, Oct 20, 2023	23-10-20
Certain Shares of Modulight Oyj are subject to a Lock-Up Agreement Ending on 21-SEP-2023.	23-09-20	CI
Pioneering Study Confirms Benefits of Modulight Oyj Technology and Photoimmunotherapy for Ovarian Cancer	23-09-06	CI
Modulight Oyj Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-18	CI
Transcript : Modulight Oyj, Q2 2023 Earnings Call, Aug 18, 2023	23-08-18
Modulight Corporation Announces Board and Committee Appointments	23-05-02	CI
Transcript : Modulight Oyj, Q1 2023 Earnings Call, Apr 28, 2023	23-04-28
Transcript : Modulight Oyj, 2022 Earnings Call, Feb 23, 2023	23-02-23
Bausch + Lomb, Modulight Get FDA OK for ML6710i, Visudyne Photodynamic Laser Treatment	23-02-01	DJ
Bausch + Lomb and Modulight Announce FDA Approval of ML6710i Photodynamic Laser for Use with B+L'sVisudyne	23-02-01	MT
Bausch + Lomb Brief: Bausch + Lomb and Modulight Announcing FDA Approval of ML6710i Photodynamic Laser for Use with BLCO's VISUDYNE (Verteporfin for Injection)	23-02-01	MT
Modulight Corp. Expands Sales in Europe Through A Distribution Partnership with Laser 2000	23-01-26	CI
FDA Approves Modulight Corp.'s ML6710i Laser Device for AMD Treatment	23-01-23	CI
Transcript : Modulight Oyj, Q3 2022 Earnings Call, Oct 20, 2022	22-10-20
Modulight Oyj(HLSE:MODU) dropped from S&P Global BMI Index	22-09-19	CI
Modulight Receives a $3.9 Million Purchase Order	22-04-20	CI
Modulight Ojy Receives Purchase Order for Pilot Project	22-03-31	CI
Modulight Oyj(HLSE:MODU) added to S&P Global BMI Index	22-03-21	CI
Modulight Corporation Announces Composition of the Board of Directors	21-09-30	CI

Chart Modulight Oyj

Duration

Period

More charts

Company Profile

Modulight Oyj is a Finland-based technology company that designs, markets and manufactures laser products, including semiconductors, laser modules, complete cloud connected laser systems and related software and analytics services for demanding medical technology and technology companies and target markets around the world. Modulight provides biomedical lasers for medical applications, including oncology, ophthalmology and genetics, as well as other diagnostics for medical and biomedical segments. Additionally, the Company offers customized biomedical laser solutions, including wavelength, optical power and laser output beam engineering enabled by its own fabrication plant and semiconductor process. Modulight Oyj is the Group's Parent Company. The Companyâs subsidiaries include Modulight China Export A Oy, Leaptek Photonics Oy, and Modulight USA Inc.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-01 - Annual General Meeting

More about the company